CNTG - Centogene regains compliance with Nasdaq's minimum bid price rule
- Nasdaq has notified the life sciences company, Centogene ( NASDAQ: CNTG ), that it has regained compliance with the stock exchange's minimum bid price requirement.
- The stock exchange said Centogene is now compliant with all applicable Nasdaq listing standards, and the matter is now considered closed.
- The company was notified of non-compliance on Dec. 12, 2022, over its common stock failing to meet the closing bid price of $1.00 or more for 30 consecutive business days.
- The deficiency was fulfilled on Feb. 3.
- Source: Press Release
For further details see:
Centogene regains compliance with Nasdaq's minimum bid price rule